Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed Maintenance in NSCLC with Impaired Renal Function (PKAPIR)
NCT03607149Phase 4Completed
- Sponsor
- Centre Georges-François Leclerc
- Start
- Apr 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Centre Georges-François Leclerc. Started Apr 2017; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03607149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03607149.